BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,444,000 | +65.6% | 9,552 | +29.9% | 0.04% | +80.0% |
| Q1 2022 | $872,000 | -76.9% | 7,356 | -73.0% | 0.02% | -80.8% |
| Q3 2021 | $3,778,000 | +793.1% | 27,200 | +168.2% | 0.10% | +166.7% |
| Q3 2019 | $423,000 | -50.1% | 10,142 | -47.6% | 0.04% | -49.4% |
| Q2 2019 | $848,000 | +53.9% | 19,360 | +32.0% | 0.08% | +42.6% |
| Q3 2018 | $551,000 | +88.1% | 14,665 | +29.1% | 0.05% | +54.3% |
| Q1 2018 | $293,000 | – | 11,358 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |